BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33993062)

  • 1. No improvement in survival of older women with cervical cancer-A nationwide study.
    Wenzel HHB; Bekkers RLM; Lemmens VEPP; Van der Aa MA; Nijman HW
    Eur J Cancer; 2021 Jul; 151():159-167. PubMed ID: 33993062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in treatment and overall survival among patients with proximal esophageal cancer.
    de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
    World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit.
    Vale CL; Tierney JF; Davidson SE; Drinkwater KJ; Symonds P
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):590-601. PubMed ID: 20594810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
    Shigeta S; Shida M; Nagase S; Ikeda M; Takahashi F; Shibata T; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
    Gynecol Oncol; 2020 Oct; 159(1):248-255. PubMed ID: 32718728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical Cystectomy
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2017 Oct; 37(10):5603-5608. PubMed ID: 28982876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined pretreatment with
    Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
    Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013.
    Bernards N; Haj Mohammad N; Creemers GJ; Rozema T; Roukema JA; Nieuwenhuijzen GA; van Laarhoven HW; van der Sangen M; Lemmens VE
    Acta Oncol; 2016; 55(9-10):1161-1167. PubMed ID: 27174793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
    Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
    Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups.
    Macchia G; Cerrotta A; Deodato F; Pappalardi B; Santoni R; Campitelli M; Scambia G; Valentini V; Aristei C; Ferrandina G
    Crit Rev Oncol Hematol; 2020 May; 149():102925. PubMed ID: 32200268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year outcome of concurrent radiotherapy and chemotherapy in Saudi women with locally advanced cervical cancer: single-institution experience.
    Al Asiri M; Tunio M; Al Hadab A; Mohamed R; Bayoumi Y; Al Saeed E; Al Arifi M; Al Amro A
    Ann Saudi Med; 2013; 33(4):327-33. PubMed ID: 24060709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
    Hermans TJN; Fransen van de Putte EE; Horenblas S; Lemmens V; Aben K; van der Heijden MS; Beerepoot LV; Verhoeven RH; van Rhijn BWG
    Eur J Cancer; 2016 Feb; 54():18-26. PubMed ID: 26707593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
    Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand.
    Tharavichitkul E; Klunkin P; Lorvidhaya V; Sukthomya V; Chakrabhandu S; Pukanhaphan N; Chitapanarux I; Galalae R
    J Radiat Res; 2012; 53(2):281-7. PubMed ID: 22510600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Tian T; Gao X; Ju Y; Ding X; Ai Y
    Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
    Manders DB; MorĂ³n A; McIntire D; Miller DS; Richardson DL; Kehoe SM; Albuquerque KV; Lea JS
    Am J Clin Oncol; 2018 May; 41(5):447-451. PubMed ID: 27258678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy.
    Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
    Brachytherapy; 2016; 15(6):845-850. PubMed ID: 27720204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.